MRAI
MRAI 1-star rating from Upturn Advisory

Marpai Inc (MRAI)

Marpai Inc (MRAI) 1-star rating from Upturn Advisory
$0.65
Last Close (24-hour delay)
upturn advisory logo
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/24/2025: MRAI (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

1 star rating from financial analysts

1 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $6

1 Year Target Price $6

Analysts Price Target For last 52 week
$6 Target price
52w Low $0.64
Current$0.65
52w High $1.78

Analysis of Past Performance

Type Stock
Historic Profit -59.68%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 3.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/24/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 15.62M USD
Price to earnings Ratio -
1Y Target Price 6
Price to earnings Ratio -
1Y Target Price 6
Volume (30-day avg) 1
Beta 4.6
52 Weeks Range 0.64 - 1.78
Updated Date 12/26/2025
52 Weeks Range 0.64 - 1.78
Updated Date 12/26/2025
Dividends yield (FY) -
Basic EPS (TTM) -2.92

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -58.4%
Operating Margin (TTM) -68.64%

Management Effectiveness

Return on Assets (TTM) -41.2%
Return on Equity (TTM) -1359.59%

Valuation

Trailing PE -
Forward PE -
Enterprise Value 18848382
Price to Sales(TTM) 0.75
Enterprise Value 18848382
Price to Sales(TTM) 0.75
Enterprise Value to Revenue 0.54
Enterprise Value to EBITDA -0.89
Shares Outstanding 23880611
Shares Floating 13165612
Shares Outstanding 23880611
Shares Floating 13165612
Percent Insiders 48.75
Percent Institutions 7.41

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI SWOT

Marpai Inc

Marpai Inc(MRAI) company logo displayed in Upturn AI summary

Company Overview

Company history and background logo History and Background

Marpai, Inc. (NASDAQ: MRAI) is a technology company focused on leveraging artificial intelligence (AI) to disrupt the insurance industry, particularly in the health insurance sector. The company was founded with the goal of creating a more efficient, transparent, and personalized insurance experience. Marpai's evolution has been centered on developing and deploying its proprietary AI-driven platform for underwriting, claims processing, and customer service.

Company business area logo Core Business Areas

  • AI-Powered Insurance Platform: Marpai's core business revolves around its AI platform, which aims to automate and optimize various aspects of the insurance lifecycle. This includes underwriting for risk assessment, claims adjudication for faster processing, and data analytics for better customer insights and product development.
  • Health Insurance Solutions: While the AI platform is foundational, Marpai has a strong focus on health insurance. They aim to offer innovative health insurance products and services, particularly for employer-sponsored plans, by utilizing their technology to reduce administrative costs and improve member outcomes.

leadership logo Leadership and Structure

Marpai's leadership team comprises individuals with expertise in technology, AI, and the insurance industry. The company operates with a lean structure focused on innovation and technology development, supported by a dedicated sales and operations team.

Top Products and Market Share

Product Key Offerings logo Key Offerings

  • AI Underwriting Engine: Marpai's AI underwriting engine analyzes vast datasets to provide more accurate risk assessments, leading to potentially better pricing and coverage. Market share data for this specific product is not publicly available as it's an integrated component of their offerings. Competitors include traditional underwriting software providers and other InsurTech companies developing similar AI solutions.
  • AI Claims Processing: This service utilizes AI to automate and expedite the claims adjudication process, reducing manual effort and potential for error. Specific market share figures are not disclosed. Competitors include existing claims management software vendors and other AI-driven claims processing solutions.
  • AI-Driven Health Insurance Plans: Marpai offers health insurance plans that are designed and managed with the assistance of their AI technology, aiming for cost savings and personalized member experiences. Market share in the broader health insurance market is nascent for Marpai, as they are a newer entrant. Competitors are numerous, ranging from large national insurers like UnitedHealth Group (UNH), Anthem (now Elevance Health - ELV), and Aetna (a CVS Health company - CVS), to smaller regional providers.

Market Dynamics

industry overview logo Industry Overview

The health insurance industry is a massive, highly regulated, and competitive market. There is a growing trend towards leveraging technology, including AI and data analytics, to improve efficiency, personalize offerings, and manage costs. The InsurTech sector is rapidly evolving, with companies aiming to disrupt traditional models.

Positioning

Marpai positions itself as a forward-thinking InsurTech company using AI to fundamentally change how insurance is underwritten, managed, and delivered. Their competitive advantage lies in their proprietary AI technology, which they believe offers superior efficiency and data-driven insights compared to legacy systems.

Total Addressable Market (TAM)

The TAM for health insurance is enormous, measured in trillions of dollars globally and hundreds of billions of dollars in the US. Marpai is positioned to capture a share of this market by targeting specific segments, such as employer-sponsored health plans, where they believe their AI solutions can deliver significant value and cost savings. However, their current market penetration is small relative to the overall TAM.

Upturn SWOT Analysis

Strengths

  • Proprietary AI technology with potential for significant efficiency gains.
  • Focus on a high-growth and critical market (health insurance).
  • Potential for reduced administrative costs and improved accuracy through AI.
  • Agile and innovative approach compared to established insurers.

Weaknesses

  • Relatively new company with limited brand recognition and market share.
  • Dependence on the successful adoption and integration of its AI technology.
  • Significant capital requirements for scaling and market penetration.
  • Challenges in navigating the complex regulatory landscape of the insurance industry.

Opportunities

  • Growing demand for AI and technology solutions in the insurance sector.
  • Potential for partnerships with larger insurance carriers or healthcare providers.
  • Expansion into other insurance lines beyond health.
  • Increasing adoption of data-driven decision-making by businesses.

Threats

  • Intense competition from established insurers and other InsurTech startups.
  • Regulatory changes that could impact AI deployment or data usage.
  • Cybersecurity risks and data privacy concerns.
  • Challenges in attracting and retaining top AI and insurance talent.

Competitors and Market Share

Key competitor logo Key Competitors

  • Elevance Health Inc. (ELV)
  • UnitedHealth Group Inc. (UNH)
  • CVS Health Corporation (CVS) - includes Aetna
  • Cigna Group (CI)
  • Humana Inc. (HUM)

Competitive Landscape

Marpai faces significant challenges from large, established players with deep pockets, extensive customer bases, and sophisticated existing infrastructure. Marpai's advantage lies in its cutting-edge AI technology, which could offer differentiation and cost efficiencies. However, overcoming the inertia and trust associated with incumbent insurers is a major hurdle.

Growth Trajectory and Initiatives

Historical Growth: Marpai's historical growth has been characterized by its focus on developing its AI platform and securing initial partnerships or pilot programs. Growth has been driven by technological innovation and strategic investments rather than established revenue streams.

Future Projections: Future projections for Marpai are contingent on its ability to scale its AI solutions, secure significant customer contracts, and gain market traction. Analysts may project future revenue growth based on the increasing adoption of InsurTech solutions and the market size of health insurance, but this is subject to considerable uncertainty.

Recent Initiatives: Recent initiatives likely include further development of its AI algorithms, expanding its sales and marketing efforts, and forging strategic partnerships within the healthcare and insurance ecosystems.

Summary

Marpai Inc. is an emerging InsurTech company with a strong focus on AI for the health insurance market. Its proprietary technology offers the potential for significant disruption and efficiency gains. However, the company faces immense competition from established giants and must navigate complex regulations and substantial capital requirements to achieve meaningful market share and profitability. Success hinges on effective scaling of its AI solutions and successful market adoption.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company filings with the U.S. Securities and Exchange Commission (SEC)
  • Reputable financial news outlets and industry analysis reports
  • Financial data aggregators

Disclaimers:

This JSON output is based on publicly available information and general industry knowledge. It is not intended as financial advice. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions.

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Marpai Inc

Exchange NASDAQ
Headquaters Tampa, FL, United States
IPO Launch date 2021-10-27
CEO & Director Mr. Damien Francis Lamendola
Sector Healthcare
Industry Healthcare Plans
Full time employees 117
Full time employees 117

Marpai, Inc., together with its subsidiaries, operates as a technology-driven healthcare payer company in the United States. The company offers third-party administrator and value-oriented health plan services to employers that directly pay for employee health benefits. It also provides in-house ancillary services that include clinical care management, a nurse-led guide for at-risk members across the care continuum; repricing insights, which are out-of-network claims; Marpai PACCS, a pharmacy advocacy cost containment solution that is a member-driven pharmacy savings program; and MarpaiRx, a national pharmacy benefit management program. In addition, the company offers health plan administration services, third-party vendor services, and complementary services, such as case management, actuarial, and bill review services. It serves the self-insured employer market through healthcare benefits brokers and consultants. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.